Quarterly report pursuant to Section 13 or 15(d)

Marketable securities held (Details Narrative)

v2.4.0.8
Marketable securities held (Details Narrative) (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2014
Marketable Securities Held Details Narrative    
Exchange shares   1,200,000
Portion of shares in escrow 260,000 600,000
Non-escrowed shares price per share $ 10.00 $ 10.00
Non-escrowed shares   600,000
Shares released 90,000 90,000
Recognized loss on return of shares $ 584 $ 584
Fair value of released shares 1,188 1,188
Unrealized gain 604 604
Escrowed shares 510,000 510,000
Claim made by MusclePharm   3,037
Musclepharm repurchase of shares 2,500 2,500
Fair value of the Call Option 363 363
Fair value of escrowed Musclepharm securities net 3,042 3,042
Fair value of escrowed Musclepharm securities gross $ 3,406 $ 3,406